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ABSTRACT
RNA-binding protein HuR modulates the stability
and translational efficiency of messenger RNAs
(mRNAs) encoding essential components of the
cellular proliferation, growth and survival
pathways. Consistent with these functions, HuR
levels are often elevated in cancer cells and
reduced in senescent and quiescent cells.
However, the molecular mechanisms that control
HuR expression are poorly understood. Here we
show that HuR protein autoregulates its abundance
through a negative feedback loop that involves
interaction of the nuclear HuR protein with a
GU-rich element (GRE) overlapping with the HuR
major polyadenylation signal (PAS2). An increase
in the cellular HuR protein levels stimulates the
expression of long HuR mRNA species containing
an AU-rich element (ARE) that destabilizes the
mRNAs and thus reduces the protein production
output. The PAS2 read-through occurs due to a
reduced recruitment of the CstF-64 subunit of the
pre-mRNA cleavage stimulation factor in the
presence of the GRE-bound HuR. We propose that
this mechanism maintains HuR homeostasis in
proliferating cells. Since only the nuclear HuR is
expected to contribute to the auto-regulation, our
model may explain the longstanding observation
that the increase in the total HuR expression in
cancer cells often correlates with the accumulation
of its substantial fraction in the cytoplasm.
INTRODUCTION
Eukaryotes employ multiple posttranscriptional mechan-
isms to adjust their gene expression programs in response
to external cues and changes in the physiological status of
the cell (1,2). A major part in the posttranscriptional hier-
archy is played by RNA-binding proteins (RBPs) that
regulate virtually every aspect of the messenger RNA
(mRNA) metabolism, from nuclear processing reactions
and export to the cytoplasm to translation and stability
(3,4). The extent of this regulatory paradigm is illustrated
by the fact that hundreds of distinct RBPs are encoded in
mammalian genomes and many of these proteins still
await their detailed functional characterization (5).
Most RBPs interact with fairly short or degenerate
RNA elements that occur in many RNA species (6,7).
Interestingly, mRNAs encoding components of a speciﬁc
biological pathway often contain binding sites for a par-
ticular RBP or a group of related RBPs, which may facili-
tate coordinated regulation of these mRNA species (8,9).
A striking example of such regulatory network is provided
by a cohort of RBPs involved in mRNA turnover and/or
translation regulation (TTR-RBPs) (10). Examples of
TTR-RBPs include AUF1/hnRNP D, BRF1, KSRP,
tristetraprolin (TTP), TIA1 and TIAR proteins, as well
as four mammalian homologs of the Drosophila ELAV
protein (embryonic lethal abnormal vision): the ubiqui-
tously expressed HuR/HuA/ELAVL1 and the nervous
system-speciﬁc HuB/ELAVL2, HuC/ELAVL3 and HuD/
ELAVL4 proteins (10–13).
Similar to other TTR-RBPs, Hu proteins normally
function by interacting with AU- or U-rich sequence
elements (ARE) frequently found within 30-untranslated
regions (30-UTRs) and sometimes other parts of mRNAs
encoding proto-oncogenes, cytokines, lymphokines and
other functionally coherent protein subsets (12,14–17).
Hu proteins tend to stimulate mRNA stability and trans-
lational efﬁciency, although in several cases they have
been shown to promote mRNA decay or repress its trans-
lation (10,12,14–16,18–31).
HuR protein and its nervous system-speciﬁc paralogs
contain three RNA-recognition motif (RRM) domains.
Of these, the two N-terminal domains bind U-rich RNA
sequences whereas the C-terminal RRM has been
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sequences and be involved in protein-protein interactions
[(15) and references therein]. The second and the third
RRMs are connected by a basic hinge peptide contain-
ing the HuR nucleocytoplasmic shuttling sequence
(HNS) (32). HuR protein localizes predominantly to the
nucleus; however, its cytoplasmic fraction has been
reported to increase transiently at speciﬁc stages of the
cell cycle or in response to stress and growth factors
(16,27,28,30,33–35).
In addition to their involvement in the mRNA stability
and translation pathways, Hu proteins have been
implicated in regulation of multiple alternative
pre-mRNA splicing and cleavage/polyadenylation events
in the nucleus (15,17,36–38), evocative of the similar
activities of the Drosophila ELAV protein (39–41).
Pre-mRNA cleavage and polyadenylation in metazoan or-
ganisms rely on the activity of several protein factors
(42–44). Of these, cleavage/polyadenylation speciﬁcity
factor (CPSF) binds to the polyadenylation signal (PAS)
and catalyzes the pre-mRNA cleavage. The 30-end of the
cleaved pre-mRNAs is then polyadenylated by the nuclear
polyadenylate polymerase (PAP). Other important com-
ponents of the cleavage/polyadenylation machinery are
cleavage factors I and II (CFI and CFII) and the
cleavage-stimulation factor (CstF). The CstF-64 subunit
of the CstF interacts with GU-rich sequence elements that
normally occur downstream of the future cleavage site
[downstream sequence elements(DSEs)]. Notably, Hu
proteins may compete with CstF-64 for binding to
U-rich sequences adjacent to the PASs of some cellular
and viral pre-mRNAs (37).
Despite the advanced state of our knowledge of the
HuR functions, the mechanisms regulating its expression
are not understood completely. Cellular HuR protein
abundance may undergo major changes in speciﬁc physio-
logical situations. For example, it is dramatically reduced
in HeLa cells during heat shock as a result of proteosome-
dependent degradation (45). HuR protein levels are also
diminished in senescent and quiescent cells (33,46). In sen-
escent cells, this effect appears to be mediated by a positive
feedback auto-regulatory loop, in which interaction of
HuR protein with the 30-UTR of its own mRNA is
required for the mRNA export from the nucleus to the
cytoplasm (46). Since the HuR protein localization in
senescent cells is exclusively nuclear, the export of
the HuR mRNA is arrested leading to its reduced trans-
lation (46).
Several alternatively polyadenylated isoforms have been
described for both human and mouse HuR mRNAs
(47,48). Although the mechanism regulating the PAS
choice is currently unknown, the longer mRNA isoforms
encoding human HuR have been shown to be destabilized
by a functional ARE sequence (48). Interestingly,
overexpressed HuR protein partially rescued the sta-
bility of these mRNA species (48), which might poten-
tially provide another positive feedback mechanism
contributing to the reduced HuR expression in senescent
cells or under some other circumstances.
On the other hand, the HuR levels are often increased in
tumors as compared to the normal cells of the respective
lineages (22,49,50). This is often accompanied by the HuR
accumulation in the cytoplasm, which may increase the
expression of proto-oncogenes, anti-apoptotic and
pro-metastatic proteins, angiogenic growth factors and
immunosuppressive cytokines, and decrease the expres-
sion of tumor suppressors (14,16,19,21,22,50–52). The
cellular HuR levels and its cytoplasmic localization may
therefore be used as prognostic markers for tumor severity
(51–63). The elevated HuR expression in cancer cells may
in part be due to the reduced levels of microRNAs
miR-16, miR-125 or/and miR-519 that have been shown
to target the HuR mRNA (64–67). However, it is not clear
whether the lack of repression by these three miRNAs is
sufﬁcient to account for the elevated HuR expression in all
cancer types. Moreover, the possible causative link
between the cytoplasmic accumulation and the total
HuR expression has not been studied.
Notwithstanding the above examples, HuR levels
remain relatively constant throughout the cell cycle and
during several forms of stress other than heat shock
(27,35,45). This may suggest the existence of an
unknown homeostatic mechanism controlling the HuR
expression in proliferating cells. Interestingly, the expres-
sion of the ELAV protein in Drosophila is autoregulated
through a negative feedback loop, which involves ELAV
protein-regulated switch in the alternative splicing pattern
of the ELAV pre-mRNA (41,68). In this study, we
investigated the mechanisms controlling the HuR abun-
dance in proliferating mammalian cells.
MATERIALS AND METHODS
Plasmids
Full-length mouse HuR 30-UTR was PCR-ampliﬁed
from BAC RP24-147J6 (BACPAC Resources Center at
Children’s Hospital Oakland Research Institute,
Oakland, CA, USA) using KAPA HiFi DNA polymerase
(KAPA Biosystems) and EMO224/EMO225 primers
(Supplementary Table S1) and cloned into the
psiCHECK-1 vector (Promega) to generate pEM429
plasmid (also referred to as RLuc-30HuR-wt). To con-
struct pEM430 plasmid (RLuc-30HuR-PAS2mut), the
PAS2 sequence in pEM429 was mutated with EMO128/
EMO129 primers (Supplementary Table S1; mutated nu-
cleotides underlined) using a modiﬁed Quikchange
site-directed mutagenesis protocol (Stratagene), in which
PfuTurbo was substituted with KAPA HiFi DNA poly-
merase. ARE sequence was deleted from pEM429 and
pEM430 using mutagenic primers EMO1117/ EMO1118
(Supplementary Table S1) giving rise to pEM801
(RLuc-30HuR-ARE) and pEM657 (RLuc-30HuR-
PAS2mut/ARE), respectively. Reporter plasmid con-
taining mouse HuR ARE (pEM806) was created by
cloning the corresponding PCR product (EMO1646/
EMO1647; Supplementary Table S1) into the
psiCHECK-1 vector. To construct a lentiviral plasmid
encoding a HuR-speciﬁc shRNA (pEM505), annealed
EMO835/EMO836 oligonucleotides (Supplementary
Table S1) were cloned into the pTRIPZ vector (Open
Biosystems, Huntsville, AL, USA) at the XhoI and
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generate the pEM821 plasmid, the fragment encoding the
SV40 large T antigen (LTA) was removed from pSV3-neo
using AvaI and HpaI (NEB). pBOS-T7-HuR and
pEF-BOS have been described previously (69,70). Vector
pEM705 encoding a bicistronic dTomato-IRES-EGFP
cassette ﬂanked with Lox2272 and LoxP sites has been
described (71). To prepare the pEM725 plasmid for
HILO-RMCE knock-ins of the T7-HuR gene,
pBOS-T7-HuR-derived PCR fragment ampliﬁed with
EMO1088/EMO1089 (Supplementary Table S1) was
cloned at the XhoI–NotI sites of the pEM705 vector in
place of the dTomato-IRES-EGFP cassette. To generate
the pEM707 and pEM708 plasmids, the wild-type or the
PAS2-mutated GU-rich element (GRE)/PAS2 fragments
were ampliﬁed from pEM429 or pEM430, respectively,
using EMO703/EMO704 (Supplementary Table S1).
The PCR fragments were digested with PstI–EcoRI
(underlined) and cloned into pEM705 at the NsiI–MfeI
sites. Plasmids pEM849 and pEM850 encoding the
GRE and the ARE-containing fragments used in the
biotinylated RNA pull-down assays were generated by
cloning the corresponding PCR fragments ampliﬁed
with EMO703/EMO704 and EMO1518/EMO1519
primer pairs (Supplementary Table S1) into the
pCR4Blunt-TOPO vector (Invitrogen). Maps of all pEM
plasmids are available upon request.
Cell cultures
Cell lines were obtained from ATCC and propagated at
37 C in the presence of 5% CO2. HEK293T, HeLa, HeLa
S3, L929, and NIH 3T3 were cultured in DMEM/High
glucose medium (Hyclone) supplemented with 10%
Fetal Bovine Serum (FBS, Characterized grade;
Hyclone), 1mM sodium pyruvate (Invitrogen) and 1 
penicillin-streptomycin (100U/ml penicillin, 100mg/ml
streptomycin; Invitrogen). P19 cells were cultured in
aMEM medium containing 10% FBS and 1  penicillin–
streptomycin. When required, media were supplemented
with 5mg/ml blasticidin S, 2–5mg/ml puromycin or 2mg/ml
doxycycline. Lipofectamine 2000 (Invitrogen) was used to
transfect cells with plasmid DNA as recommended.
Transgene integration using recombination-mediated
cassette exchange
The high efﬁciency/low background (HILO) recombination-
mediated cassette exchange (RMCE) procedure has been
described elsewhere (71). Brieﬂy, P19 and NIH 3T3 cells
were transduced with a lentiviral vector encoding a Cre
RMCE acceptor site comprised of a blasticidin S resist-
ance gene (Bsd) ﬂanked by the mutually incompatible
Lox2272 and LoxP sites. The blasticidin-resistant clones
containing a single genomic copy of the proviral acceptor
site were co-transfected with a modiﬁed version of the Cre
recombinase-expressing plasmid pCAGGS-Cre (72) and
an RMCE donor plasmid containing a desired cassette
ﬂanked by the Lox2272 and LoxP sites. The donor
plasmids additionally contained a puromycin resistance
marker, which allowed the selection of the correctly
recombined cell populations with puromycin.
RNA interference
ON-TARGETplus SMARTpool siRNAs against mouse
HuR or TTP (Dharmacon/Thermo Scientiﬁc) were de-
livered into cells using Lipofectamine 2000 (Invitrogen)
as recommended. Cells transfected with siRNAs were har-
vested 78h post-transfection. Lentivirus vector encoding a
HuR-speciﬁc shRNA was prepared by co-transfecting
HEK293T cells with the pEM505 plasmid and the
Lenti-X HT packaging mix using Lentiphos HT transfec-
tion reagent (Clontech) as recommended. Medium was
changed 12h after transfection and the plate was
incubated for another 48h before collecting the super-
natant containing the lentivirus vector particles. The
supernatant was cleared from the cellular debris by cen-
trifugation at 1000g for 5min and frozen at  80 Ci n
small, single use aliquots. Virus titers were determined
using HEK293T cells as recommended (Open
Biosystems). Stable cell lines were obtained from individ-
ual lentivirus-transduced puromycin-resistant colonies.
shRNA expression was induced with doxycycline for
48–72h.
Reverse transcription–quantitative PCR
Reverse transcription–quantitative PCR (RT–qPCR) was
carried out as described (73). Brieﬂy, total RNA was
puriﬁed from cell cultures using Trizol (Invitrogen) as rec-
ommended. RNA samples were treated with 50 units/ml
of RQ1 DNase (Promega) at 37 C for 30min to remove
genomic DNA contamination. Reverse transcription (RT)
was carried out using SuperScript III (Invitrogen) and
random decamer (N10) primers at 50 C for 1h. cDNA
samples were analyzed by quantitative PCR using Fast
SYBR Green Master Mix and a StepOnePlus Real-Time
PCR System (Applied Biosystems) as recommended.
Primers used for qPCR are listed in Supplementary
Table S1. The expression of targets of interest was
normalized to the expression level of the Hprt gene
(primers EMO592/593; Supplementary Table S1).
Reactions were performed in triplicate.
In vitro pre-mRNA cleavage assays
Radiolabeled RNA substrates for the cleavage assays were
prepared using T7 RNA polymerase transcription as rec-
ommended (Promega). Reactions (20ml) contained 50 uCi
of [a-
32P]UTP (Perkin Elmer), 0.8mM Ribo m
7G Cap
analog (Promega) and 1mg of either pEM810 plasmid
linearized with PmeI (NEB) or pEM811 plasmid
linearized with EcoRI (NEB). Following 1.5h incubation
at 37 C, the labeled RNAs were treated with RQ1 DNase
(Promega; 1 unit/1mg of template DNA) for 15min at
37 C, extracted with a 1:1 mixture of phenol and chloro-
form, precipitated with ethanol and rehydrated in
DEPC-treated water (Invitrogen). Pre-mRNA cleavage
assays were carried out in principle as described (74).
Reaction mixtures (25ml) contained 40% (v/v) HeLa S3
nuclear extract (dialyzed against buffer D containing
20mM HEPES, pH 7.9, 1.5mM MgCl2, 100mM KCl,
20% Glycerol, 0.5mM DTT and 0.05mM EDTA),
0.08mM ATP (Promega), 1mM cordycepin (Sigma),
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0.01% NP-40, 2mM DTT, 10U rRNAsin (Promega),
0.1mg/ml yeast tRNA and 60fmol of
32P-labeled sub-
strate RNA. Reactions were incubated at 30 C for 2.5h
followed by digestion with 0.8mg/ml proteinase K
(Fermentas) at 37 C for 15min. The reactions were ex-
tracted with phenol-chloroform, precipitated with
ethanol and analyzed by 5% polyacrylamide-7M urea
gel electrophoresis. The radioactive signals were visualized
using a Typhoon Trio imager (GE Healthcare).
Biotinylated RNA pull-down assays
Biotinylated RNA probes were prepared using in vitro
transcription of appropriate linearized plasmid templates
with T7 or T3 RNA polymerases (Promega) in the
presence of the biotin-UTP labeling NTP mixture
(Roche) as recommended. The reactions were incubated
for 2h at 37 C, followed by incubation with RQ1 DNase
(Promega; 1U/1mg of template DNA) for 15min at 37 C.
The biotinylated RNAs were then extracted with
phenol-chloroform (1:1) mixture, precipitated with
ethanol and rehydrated in DEPC-treated water. HuR/
RNA complexes were allowed to form at room tempera-
ture for 30min in 20ml mixtures containing 2mg
biotinylated RNA probe, 40% (v/v) nuclear extract
( 100mg in total), 4mg yeast tRNA, 50mg heparin and
40 units of rRNasin (Promega), 20mM Hepes–KOH,
pH 7.9, 20% glycerol, 100mM KCl, 0.2mM EDTA,
0.5mM DTT (in addition to the concentrations of these
components in the nuclear extract). CstF-64/RNA
complexes were assembled at 30 C for 20min in 50ml re-
actions containing 1mg biotinylated RNA probe, con-
tained 40% (v/v) nuclear extract diluted with buffer D
to 1mg/ml (i.e. 20mg in total), 2mg yeast tRNA, 0.8mM
ATP. The complexes were further stabilized by UV
cross-linking at 254nm, 1.8J/cm
2, 0.01% NP-40, 2mM
DTT, 20mM phosphocreatine, 10U of rRNAsin
(Promega). Both HuR/RNA and the UV-cross-linked
CstF-64/RNA complexes were then incubated with 10ml
Streptavidin Sepharose (Sigma) for 1h at 4 C followed by
three washes with 8mM HEPES–KOH, pH 7.9, 0.6mM
MgCl2, 40mM KCl, 8% Glycerol, 0.2mM DTT and
0.02mM EDTA. The bead-associated proteins were
eluted by treating the beads with 1mg/ml RNAse A for
15min at 37 C (this step was omitted for the HuR/RNA
complexes) followed by boiling with SDS–PAGE loading
buffer for 5min. The eluted proteins were analyzed by
immunoblotting.
Estimating mRNA half-lives
HEK293T cells were transfected with pEM429
(RLuc-30HuR-wt) or pEM430 (RLuc-30HuR-PAS2mut)
plasmids overnight to allow the expression of the corres-
ponding RLuc mRNAs. On the next day, the RNA poly-
merase II inhibitor actinomycin D (Sigma) was added to
cultures to the ﬁnal concentration of 5mg/ml and the total
cellular RNA was extracted with Trizol at 0–8-h time
points. RT–qPCR with RLuc-speciﬁc primers
(EMO1264/EMO1265; Supplementary Table S1) was
used to follow the mRNA degradation time course of.
The data normalized to the RPLP0 mRNA RT–qPCR
signals (primers EMO2185/EMO2186; Supplementary
Table S1) were plotted as a function of the actinomycin
D treatment time and ﬁtted to a single exponential decay
function to determine the apparent mRNA half-lives.
RNA immunopreciptation
Ten million NIH 3T3 cells UV cross-linked at 254nm,
0.4J/cm
2 were either directly resuspended in the lysis
buffer [50mM HEPES (pH 7.0), 60mM KCl, 5mM
MgCl2 and 0.5% NP-40, 1mM DTT, 0.1U/ml rRNasin]
or used to prepare nuclear extracts with the NE-PER kit
(Pierce) as recommended. The extracts pre-cleared by in-
cubation with protein A or G Sepharose beads (GE) at
4 C for 4h were incubated with rabbit anti-HuR antibody
(Millipore), anti-CstF4 mouse monoclonal antibody
(clone 3A7; a gift from Clinton MacDonald, Texas Tech
University) or corresponding preimmune IgG controls at
4 C overnight. The antigen-antibody complexes were
mixed with protein A or G beads, as appropriate, and
incubated at 4 C for 4h with constant agitation. The
beads were washed with the lysis buffer followed by incu-
bation with the lysis buffer suspplemented with 0.1% SDS
and 0.5mg/ml proteinase K (Ferments) at 50 C for
30min. RNAs were extracted with phenol–chloroform
and precipitated with ethanol. Traces of genomic DNA
were removed by incubating the samples with RQ1
DNase (Promega) for 15min at 37 C, which was
followed by RT–PCR analyses with either mouse
HuR-speciﬁc primers designed to amplify a cDNA
fragment spanning the 30-terminal exon–exon junction
(EMO2294/2295; Supplementary Table S1) or similarly
designed Hprt-speciﬁc primers (EMO592/593;
Supplementary Table S1).
RESULTS
Mouse HuR expression is autoregulated by a negative
feedback mechanism
To understand the regulation of HuR expression in
proliferating mammalian cells, we integrated a single
copy of a constitutively expressed T7 epitope-tagged
mouse HuR transgene into the P19 mouse embryonic
carcinoma cell genome using the high-efﬁciency and
low-background recombination-mediated cassette
exchange (HILO-RMCE) technique recently developed
in our laboratory (Figure 1A). Using immunostaining
with T7 tag-speciﬁc antibodies we conﬁrmed that virtually
all cells in the transgenic populations expressed T7-HuR
at comparable levels and that the protein showed predom-
inantly nuclear localization, similar to the endogenous
HuR (Figure 1B and data not shown). The T7 epitope
allowed us to distinguish between the transgenic and the
endogenous HuR proteins based on their distinct electro-
phoretic mobilities. Notably, the presence of the T7-HuR
protein correlated with a noticeable reduction in the ex-
pression of the endogenous HuR protein in two independ-
ently generated transgenic cell populations as compared to
the HuR level in the parental P19 cells (Figure 1C).
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integrated the T7-HuR expression cassette into the
genome of mouse NIH 3T3 cells using HILO-RMCE
and analyzed the expression of the transgenic and en-
dogenous HuR proteins by immunoblot (Figure 1D).
The transgenic T7-HuR appeared to be expressed in
NIH 3T3 more efﬁciently than in P19, potentially due to
a higher CAG activity in the former line. The T7-HuR
overexpression diminished the expression of the endogen-
ous HuR to a dramatically low level as compared to the
control transgenic cells lacking the T7-HuR gene
(Figure 1D). We concluded that the expression of the
mouse HuR gene may be regulated by a negative
feedback mechanism.
HuR 30-UTR contains cis-elements responsible for the
negative autoregulation
To test if, similar to the Drosophila ELAV protein, the
HuR protein may repress its expression by interacting
with the 30-terminal part of its pre-mRNA, we generated
a Renilla reniformis luciferase reporter gene fused with a
 5kb fragment comprising the 30 untranslated region
(30-UTR) of the mouse HuR gene (RLuc-30HuR). The
30-UTR of the mouse HuR gene contains several alterna-
tive PASs including PAS1, PAS2, PAS3 and ﬁve closely
positioned signals that we refer to as PAS4a-e (Figure 2A).
Of these, PAS2 appears to be used most frequently since it
is supported by the largest number of sequenced cDNA
clones (Figure 2B). When human embryonic kidney
(HEK) 293T cells were co-transfected with the
RLuc-30HuR construct and either a T7-HuR expression
plasmid (pBOS-T7-HuR) or the corresponding empty
vector (pEF-BOS), the RLuc expression was reduced
4.7-fold (P=2.7 10
 4; t-test) in the presence of
T7-HuR as compared to the pEF-BOS control
(Figure 2C). In contrast, T7-HuR did not affect the ex-
pression of the control RLuc construct containing a
30-UTR sequence from the SV40 virus (Figure 2C).
Thus, the mouse HuR 30-UTR contains sequence(s)
mediating the negative feedback regulation.
HuR protein differentially regulates the abundance of
different alternatively polyadenylated forms of its mRNA
To examine whether the excess of the HuR protein re-
pressed the RLuc-30HuR expression by reducing the
mRNA abundance, we repeated the co-transfection ex-
periment and analyzed the RNA samples by RT–qPCR.
Four primer pairs were designed to account for the possi-
bility of alternative PAS usage (F1/R1, F2/R2, F3/R3 and
F4/R4; Figure 2A). Quantitative ampliﬁcation of frag-
ments upstream of the PAS2 indicated that the
RLuc-30HuR mRNA expression indeed decreased
2.5–2.6-fold (P<0.001; t-test) in the T7-HuR sample as
compared to the pEF-BOS control (Figure 2D).
Figure 1. Endogenous HuR protein levels are reduced in cells constitutively expressing a HuR transgene. (A) Diagram outlining the HILO-RMCE
procedure used to obtain P19 and NIH 3T3 cells constitutively expressing T7-tagged HuR transgene. (B) Immunoﬂuorescence analysis of the
T7-HuR expression in a transgenic P19 population conﬁrming that virtually all cells express this protein at comparable levels. Note that the
T7-HuR protein is concentrated in the nucleus and undetectable in the cytoplasm in a majority of the interphase cells (e.g. the cell indicated
with the white arrowhead). In a fraction of interphase cells, T7-HuR is predominantely nuclear but also detected in the cytoplasm (yellow arrow-
head), consistent with the nucleocytoplasmic HuR shuttling during the cell cycle (16,27,33). Finally, T7-HuR occupies the entire volume of mitotic
and prometaphase cells (orange arrowhead) due to the breakdown of the nuclear envelope at these stages. (C) HuR expression in the parental P19
cells (parent) and two independently generated T7-HuR transgenic cell populations (Tg1 and Tg2) was analyzed by immunoblot. Note that the
expression of the endogenous HuR protein is reduced in the presence of the transgenic T7-HuR. (D) Immunoblot analysis of the HuR expression in
the NIH 3T3 cell population expressing the T7-HuR transgene (Tg) and control transgenic cells lacking the T7-HuR (control). Similar to (C), the
expression of the endogenous HuR protein is reduced in the presence of T7-HuR. (C and D) bTub, b-tubulin loading control.
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ing to the sequences downstream of the PAS2 increased
1.4–1.5-fold (P<0.0001; t-test) (Figure 2D). This sug-
gested that, in addition to reducing the total HuR
mRNA abundance, T7-HuR overexpression simultan-
eously caused a  3.5-fold (1.4 2.5) increase in the
expression of the mRNA forms terminated at a down-
stream PAS (Figure 2D).
We wondered if the endogenous HuR mRNA was
regulated in the similar manner. As judged by the
northern blot analysis, the predominant HuR mRNA
form terminated at the PAS2 sequence in all three
Figure 2. HuR 30-UTR is involved in the HuR auto-regulation. (A) Diagram of the mouse HuR pre-mRNA. Positions of the PASs containing the
AUUAAA hexamer are indicated by vertical blue lines. PASs containing the AAUAAA sequence are shown by vertical black lines. Yellow rectangles
represent the GRE and ARE sequences. Positions of the primer pairs used in mRNA expression analyses are marked by gray dashed lines. The plot
at the bottom shows phastCons probability values reﬂecting the likelihood of sequence conservation across placental mammalian species (81).
(B) Graph showing the number of sequences in the cDNA clone database that support the utilization of the corresponding PASs. (C) HuR
30-UTR reduces the RLuc expression in the presence of T7-HuR. HEK293T cells were co-transfected with RLuc-30HuR-wt or RLuc control
plasmids and pBOS-T7-HuR or pEF-BOS vector and the RLuc expression was estimated by luciferase activity assay. (D) Over-expression of
T7-HuR differentially regulates the expression of the recombinant RLuc mRNA forms terminated at different PASs. The transfection experiment
described in (C) was repeated and the RLuc-3HuR mRNA levels analyzed by RT–qPCR using the primer pairs depicted in (A). (E) Northern blot
demonstrating that the three mouse cell lines used in this study (P19, NIH 3T3 and L929) express predominantly PAS2-terminated HuR mRNA
species. Expected positions of the four HuR mRNA forms are marked on the left. (F and G) RT–qPCR analyses showing that the expression of the
transgenic T7-HuR protein in P19 and NIH 3T3 cells leads to a downregulation of the total HuR mRNA levels and a simultaneous increase in
the PAS4-terminated mRNA fraction. Parental P19 cells are used as a control in (F), whereas NIH 3T3 cells containing a transgenic vector sequence
are used as a control in (G). Data in (C and D) and (F and G) are averaged from three experiments ±SD.
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L929; Figure 2E). To examine if elevated HuR expression
changed the relative abundance of the alternatively
polyadenylated HuR mRNA forms, we analyzed the
parental P19 cells and the P19 cells expressing the
T7-HuR transgene by RT–qPCR with primer pairs
shown in Figure 2A. Similar to the effect on
RLuc-30HuR transcripts, the transgenic T7-HuR expres-
sion diminished the total levels of the endogenous HuR
mRNA 1.2–1.6-fold (P<0.05, t-test), while simultaneous-
ly elevating the expression of the PAS4-terminated mRNA
species 1.4–1.5-fold (P<0.05, t-test). More dramatic
changes were detected in the T7-HuR expressing NIH
3T3 cells, where the total HuR mRNA levels decreased
3.0-fold (P=3.0 10
7, t-test) and the abundance of the
PAS4 species rose 2.1-fold (P=0.02, t-test) (Figure 2G).
Taken together, these data suggest that the HuR
auto-regulation involves a change in the ratio between
its long and short mRNA species.
Two alternative models for HuR homeostasis
The longer form of the human HuR mRNA has previous-
ly been shown to contain a functional ARE sequence that
destabilized a reporter mRNA in a HuR protein-
repressible manner (48). Inspection of the mouse and
other mammalian HuR 30-UTRs revealed similar ARE
sequences downstream of the PAS2 site (Figure 2A and
Supplementary Figure S1A). On the other hand, HuR and
its mammalian paralogs have previously been shown to
repress cleavage and polydenylation at PAS sites
occurring within U-rich sequence contexts (37).
Interestingly, the mouse PAS2 is embedded within a
GRE, which is conserved across mammalian species
(Figure 2A and Supplementary Figure S1B). We therefore
considered two alternative models for the HuR
autoregulation. (i) An excess of the HuR protein can sta-
bilize the ARE-containing mRNA forms but reduce the
total RLuc-30HuR mRNA abundance through an inde-
pendent mechanism. (ii) Alternatively, HuR can inhibit
the pre-mRNA processing at the PAS2 site while failing
to provide sufﬁcient protection to the ARE-containing
mRNA species terminated at the downstream PAS se-
quences. The following experiments were carried out to
distinguish between these two possibilities.
The long forms of mouse HuR mRNA are destabilized
through an ARE-dependent mechanism
To estimate the stability of the longer forms of mouse
HuR mRNA, we inactivated the PAS2 in the
RLuc-30HuR-wt reporter construct by mutating the AU
UAAA hexamer (Supplementary Figure S1B) to AUGGA
A and analyzed the mRNA species produced from the
wild-type and the mutant genes in HEK293T cells by
northern blotting (Figure 3A and B). Four distinct
species of the RLuc-30HuR-wt transcripts were detected
that matched the predicted lengths of the corresponding
alternatively polyadenylated forms (Figure 3B). As
expected, the PAS2-terminated form was the most
abundant one. Mutation of the PAS2 site completely
blocked the pre-mRNA processing at this position and,
surprisingly, at the downstream PAS3 sequence
(Figure 3B). The functional inactivation of PAS2 and
PAS3 did not result in a proportional increase in the abun-
dance of the longer mRNA species, consistent with the
model that the PAS4-terminated transcripts are less
stable than those terminated at the upstream PASs.
Indeed, the apparent half-life of the RLuc-30HuR-
PAS2mut mRNA was noticeably shorter than that of
the RLuc-30HuR-wt mRNA (128min vs. 346min;
Figure 3C). Moreover, the RLuc-30HuR-PAS2mut con-
struct generated 8.7 times less RLuc protein than the
wild-type reporter gene (Figure 3D; P=7.0 10
 6;
t-test).
To determine whether the ARE is responsible for the
instability of the PAS4-terminated transcripts, we deleted
the ARE sequence in the wt and the PAS2mut
RLuc-30HuR reporters (Figure 3A) and repeated the
luciferase assay. The expression of the genes lacking the
ARE was signiﬁcantly higher than their ARE-containing
counterparts, which was especially evident in the
PAS2mut background (Figure 3E; 4.3-fold increase;
P=4.1 10
 8; t-test).
TTP has been shown to promote the ARE-dependent
decay of the long forms of the human HuR mRNA (48).
We therefore knocked down TTP by RNA interference
(RNAi) (Figure 3F) and analyzed the expression levels
of the PAS2mut and PAS2mut/ARE versions of the
RLuc-30HuR genes using the luciferase assay.
Down-regulation of TTP increased the expression of
PAS2mut reporter gene containing the functional ARE
sequence 2.2-fold (P=0.011; t-test), whereas the expres-
sion of the PAS2mut gene lacking the ARE did not change
signiﬁcantly (Figure 3G). We concluded that, similar to
the human HuR gene, the long forms of the mouse HuR
mRNA are destabilized by the ARE sequences and that
TTP is an essential trans-factor in this pathway.
ARE protection by the HuR protein fails to account for
the increased abundance of the long HuR mRNA form
To test if an excess of the HuR protein can rescue the
ARE-dependent instability of the PAS4-terminated
mouse HuR mRNA species, we co-transfected
HEK293T cells with the RLuc-30HuR-PAS2mut construct
and either the T7-HuR expression plasmid or
the pEF-BOS vector and assayed the RLuc activity. The
HuR overexpression had no signiﬁcant effect on the
RLuc expression (Supplementary Figure S2). However,
when we repeated the assay with a RLuc reporter contain-
ing a 244bp fragment of the mouse HuR 30-UTR
spanning the ARE sequence we detected a modest but
statistically signiﬁcant stimulation of the RLuc expression
by T7-HuR (1.4-fold; P=5.6 10
 9; Supplementary
Figure S2), in line with the previously published
results (48).
Since the ARE-dependent mRNA decay is thought to
be a predominantly cytoplasmic process, we analyzed the
intracellular localization of the T7-HuR protein transient-
ly over-expressed in the HEK293T cells by immunoﬂuor-
escence (Supplementary Figure S3). Notably, most of the
T7-speciﬁc signal was enriched in the nucleus, similar to
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Figure S3). Taken together, these data suggest that
although the HuR protein might potentially counter the
ARE-dependent decay of its mRNA under some circum-
stances, this activity does not explain the increase in the
abundance of the long HuR RNA species upon HuR
overexpression.
HuR inhibits PAS2 utilization in vivo
Given its nuclear enrichment, we wondered if the HuR
protein can regulate the use of the PAS2 site in vivo. For
this purpose, we assembled a bicistronic cassette that con-
sisted of dTomato and EGFP genes separated by a 433bp
fragment containing the mouse HuR PAS2 within its
natural context (Figure 4A). A single copy of this
cassette (Bic-PAS2wt) placed downstream of a strong con-
stitutive promoter (CAG) was stably integrated into the
P19 cell genome using HILO-RMCE. We reasoned that
the pre-mRNA processing at the PAS2 site should
produce a monocistronic dTomato mRNA whereas
skipping of the PAS2 site would generate a bicistronic
mRNA containing coding both dTomato and EGFP
coding sequences. Therefore, we knocked down HuR in
the transgenic P19 cells with HuR-speciﬁc siRNAs
(Figure 4B) and analyzed the ratio between the EGFP
and dTomato expression levels by RT-qPCR
(Figure 4C). Down-regulation of HuR led to a 1.9-fold
decrease in the EGFP/dTomato ratio (P=2.8 10
 3)a s
compared to the control samples treated with a
non-targeting siRNA. As expected, HuR knockdown did
not affect the EGFP/dTomato ratio in cells expressing a
bicistronic cassette with the mutated PAS2 (Bic-PAS2mut)
(Figure 4C).
We further analyzed the effect of HuR overexpression
on the PAS2 utilization by transiently transfecting the
Bic-PAS2wt or Bic-PAS2mut transgenic cells with a
T7-HuR expression plasmid. As expected, T7-HuR led
to an increase in the dTomato/EGFP ratio in the case of
Bic-PAS2wt but not Bic-PAS2mut (Supplementary Figure
S4). We concluded that HuR expressed at its physiological
levels partially inhibits the PAS2 utilization in
proliferating mouse cells and that an increase in the
cellular HuR concentration leads to a more complete
repression.
Figure 3. The PAS4-terminated form of the mouse HuR 30-UTR represses gene expression through an ARE-dependent mechanism. (A) Diagrams of
the RLuc reporter constructs containing the wild-type and mutant HuR 30-UTR. The PAS2 mutation (PAS2mut) converts the ATTAAA sequence to
ATGGAA. ARE corresponds to the deletion of a 66 nucleotide sequence containing the ARE sequence (Supplementary Figure S1A). (B) PAS2mut
changes the mRNA isoform pattern. HEK293T cells were transfected with either the RLuc-30HuR-wt or the RLuc-30HuR-PAS2mut constructs and
the RNA extracted from these samples analyzed by northern blotting using an RLuc coding sequence-speciﬁc probe. Note that the PAS2 inactivation
leads to the disappearance of both the PAS2 and the PAS3-terminated mRNA species and that the combined RLuc-speciﬁc signal intensities are
signiﬁcantly lower in RLuc-30HuR-PAS2mut compared to the RLuc-30HuR-wt. (C) Estimation of the apparent mRNA half-lives in HEK293T cells
transfected with either RLuc-30HuR-wt or the RLuc-30HuR-PAS2mut plasmids. (D) The transfection experiment in (B) was repeated and followed by
the luciferase activity assay. (E) Deletion of the ARE sequence rescues the expression of the RLuc-30HuR reporters. HEK293T cells were transfected
with the four constructs depicted in (A) and the luciferase activity was measured 24h post-transfection. (F and, G) The effect of TTP knockdown on
the expression of RLuc-30HuR reporters. (F) HEK293T cells were transfected with either TTP-speciﬁc siRNA (siTTP) or non-targeting control
siRNA (siControl) and the expression levels of the TTP mRNA were analyzed 48h post-transfection using RT–qPCR. (G) HEK293T cells
pre-treated with siRNAs as described in (F) were transfected with RLuc-30HuR-PAS2mut reporters with (PAS2mut) or without the ARE
sequence (PAS2mut/ARE) and the RLuc activity measured 24h after transfection.
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To examine whether the HuR protein can directly inter-
fere with its pre-mRNA processing, we carried out an
in vitro pre-mRNA cleavage assay using HeLa nuclear
extract and radioactively labeled RNA substrates. We ini-
tially tested a substrate containing the HuR PAS2
sequence in its natural context but this RNA failed to
be cleaved under a range of conditions (data not
shown). We therefore designed a composite SV40-PAS2
substrate containing the late PAS of the SV40
virus preceded by the SV40-speciﬁc sequence and
followed by the HuR-derived GU-rich DSE (Figure 5A).
This recombinant RNA was readily cleaved in vitro with
the efﬁciency comparable to that of the control substrate
containing the SV40 late polyadenylation site within
its natural viral context (compare the ﬁrst lanes in
Figure 5B and C).
Notably, the addition of increasing amounts of
puriﬁed HuR protein led to a potent inhibition of the
SV40-PAS2 cleavage (Figure 5C and D). The SV40 sub-
strate cleavage was also inhibited at high HuR concentra-
tions as previously described (37) but this effect was
substantially less pronounced than in the case of
SV40-PAS2 (Figure 5B and D). These results indicate
that the HuR protein inhibits the PAS2 utilization by
blocking the pre-mRNA cleavage reaction and that this
activity depends on the GU-rich sequences adjacent to
the PAS2.
HuR interacts with the GRE sequences adjacent
to the PAS2
Pre-mRNA cleavage normally requires the presence of a
U- or GU-rich DSE, which is recognized by the CstF-64
subunit of the cleavage stimulation factor (CstF) (42–44).
Since the HuR PAS2 occurs within GU-rich context
(Supplementary Figure S1B), we hypothesized that the
high-afﬁnity HuR binding to this sequence may interfere
with the CstF recruitment.
To test if HuR could interact with the GRE se-
quence, we carried out pull-down assays using
biotinylated RNA probes (Figure 6A). HuR interaction
with the GRE sequence was readily detacted by this
assay (Figure 6B). Comparably strong interaction was
observed when we used a probe containing the
mouse HuR ARE sequence and no interaction was
detected with a probe containing the ARE antisense
sequence. Similar results were obtained when we
repeated this experiment with HeLa and HEK293T cell
nuclear extracts (Supplementary Figure S5 and data not
shown). Thus, HuR protein physically interacts with the
PAS2-associated GRE sequence.
Figure 4. HuR represses the PAS2 utilization in vivo.( A) Bicistronic
constructs containing dTomato and EGFP coding sequences separated
with either the wild-type PAS2/GRE spacer (Bic-PAS2wt) or a similar
spacer containing mutated PAS2 sequence (Bic-PAS2mut). (B and C)
Knocking down the endogenous HuR protein stimulates the
pre-mRNA processing at the PAS2 sequence. (B) The bicistronic
constructs were integrated into the P19 cell genome using RMCE
and the corresponding stable cell populations transfected with either
a HuR-speciﬁc siRNA (siHuR) or a non-targeting control siRNA
(siControl). Total RNA samples were extracted 48h post-transfection
and the efﬁciency of HuR knockdown was analyzed by RT–qPCR (C)
RNA samples from (B) were further analyzed by RT–qPCR to deter-
mine the ratio between the EGFP and dTomato expression levels as a
measure of the pre-mRNA processing efﬁciency at the PAS2.
Figure 5. HuR inhibits pre-mRNA cleavage in vitro in a PAS2 DSE-dependent manner. (A) Diagram of the RNA substrates used in the cleavage
assay. The top RNA is from the late SV40 PAS and the bottom RNA contains the SV40-speciﬁc 50 part and the HuR PAS2-speciﬁc DSE. (B and C)
In vitro cleavage reactions carried out with
32P-labeled SV40 (B) and SV40-PAS2-DSE substrates in the presence of increasing amounts of puriﬁed
N-terminally His-tagged HuR protein. (D) Quantitation of the relative cleavage efﬁciencies from (B and C) as a function of the puriﬁed HuR
concentration added to the reaction mixtures.
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To test if the interaction of HuR with the GRE may
hinder the CstF-64 recruitment, we introduced a
doxycycline-inducible HuR-speciﬁc shRNA into the
HEK293T cell genome using lentiviral transduction and
prepared nuclear extracts from the cells that were either
preincubated for 72h with 2mg/ml doxycycline or left un-
treated. Immunoblot analysis conﬁrmed that HuR was
virtually completely depleted from the nuclear extract
upon doxycyclin treatment (Figure 6C). We then
analyzed the CstF-64 association with the GRE-speciﬁc
RNA probe using the biotinylated RNA pull-down
assay comprising an additional UV cross-linking step to
stabilize the CstF-RNA complex (Figure 6A and D). The
analysis of the streptavidin-retained fraction with a
CstF-64-speciﬁc antibody showed that the CstF-64 inter-
action with the RNA probe was considerably more efﬁ-
cient in the HuR-depleted extract than in the extract
containing the normal HuR levels (Figure 6D).
To conﬁrm that both HuR and CstF-64 can interact
with the endogenous HuR mRNA, we immunopre-
cipitated RNA–protein complexes from the NIH 3T3
Figure 6. HuR interacts with the PAS2 GRE and hinders CstF-64 binding to this sequence. (A) Diagram of the RNA pull-down assays. (B) Nuclear
extract prepared from mouse L929 cells was incubated with biotinylated RNA probes corresponding to the GRE or ARE sequences from the mouse
HuR mRNA followed by capturing the RNA–protein complexes on strepavidin beads. Control pull-down samples contained either no RNA or the
ARE antisense sequence (asARE). The analysis of the RNA-bound protein fraction by immunoblotting with anti-HuR antibodies shows that HuR
interacts with both GRE and ARE sequences in vitro.( C and D) To examine the effect of HuR knockdown on the association of CstF-64 with the
HuR GRE sequence, nuclear extracts were prepared from HEK293T cells encoding Dox-inducible shRNA against human HuR, which were cultured
either with (HuR knockdown) or without Dox (normal HuR protein levels). The pull-down experiments were then carried out using the two nuclear
extracts and the interaction of CstF-64 protein with different DSE-containing RNAs was assessed by immunoblotting. (C) Immunoblot analysis of
total nuclear extracts conﬁrming an efﬁcient HuR knockdown in cells expressing HuR-speciﬁc shRNA (Dox+) as compared to the Dox-negative
control. (D) Immunoblot analysis of the pull-down fractions showing that the CstF-64 binding to the GRE sequence is enhanced in the absence of
HuR. On the other hand, CstF-64 interaction with the SV40- and adenovirus-speciﬁc probes is not affected by the change in the HuR abundance.
(E) RNA immunoprecipitation experiment conﬁrming the interaction of the HuR and CstF-64 proteins with the endogenous HuR mRNA in NIH
3T3 cells. Note that the Hprt mRNA used here as a control efﬁciently recruits CstF-64 but not HuR (F) RNA immunoprecpitation carried out with
the nuclear fraction from transgenic NIH 3T3 cells expressing either vector sequences (control) or T7-HuR [Tg(T7-HuR)] shows dramatically
diminished interaction of CstF-64 with the HuR mRNA in the presence of T7-HuR. On the other hand, the T7-HuR expression has no effect
on the CstF-64 interaction with the Hprt mRNA.
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analyzed the samples by RT–PCR with HuR
cDNA-speciﬁc primers annealing upstream of the PAS2.
An RT–PCR product of an expected size was detected
in both immunoprecipitations and no signal was
detected in the control sample precipitated with a
pre-immune mouse IgG protein (Figure 6E). Notably,
the HuR-speciﬁc antibodies failed to efﬁciently precipi-
tate the Hprt mRNA, consistent with the absence of
extensive GU-rich sequences within this transcript
(Figure 6E). On the other hand, the anti-CstF-64
immunoprecipitation sample contained readily detectable
Hprt mRNA amounts (Figure 6E).
We then repeated the RNA immunoprecipitation
analysis using the anti-CstF-64 antibody and nuclear
extracts from transgenic NIH 3T3 cells expressing either
a control sequence or T7-HuR (Figure 6F). Strikingly, the
T7-HuR expression virtually abolished the CstF-64 inter-
action with the HuR mRNA while having no effect on the
CstF-64 interaction with the Hprt mRNA (Figure 6F). We
concluded that HuR inhibits the PAS2 utilization by
reducing the CstF-64 recruitment.
Cytoplasmic accumulation of the HuR protein in the
cytoplasm of cells expressing SV40 virus LTA correlates
with an overall increase in the HuR expression
Our results so far support the model in which HuR
controls its expression through regulating the alternative
polyadenylation of its own pre-mRNA in the nucleus.
Such mechanism could maintain the cellular HuR homeo-
stasis assuming that changes in the total HuR abundance
would translate into proportional changes in its nuclear
levels. Interestingly, cancer cells have been reported
to accumulate a larger fraction of the total HuR protein
in the cytoplasm than normal non-malignant cells
(49,51–63). Since, according to our model, only nuclear
HuR can contribute to its homeostatic auto-regulation,
an increase in the cytoplasmic HuR fraction should
result in elevated total HuR protein levels.
To test this prediction, we generated two transgenic
populations of NIH 3T3 cells, one carrying the SV40
virus LTA and a G418 resistance gene (NIH
3T3-SV3neo) and the other only the G418 resistance
gene (NIH 3T3-neo). The LTA-transformed NIH
3T3-SV3neo cells proliferated considerably faster than
the NIH 3T3-neo cells (Supplementary Figure S6A), in
line with earlier reports (75,76). Compared to the
control cells, the cytoplasmic concentration of the HuR
protein increased in the SV3neo cells whereas its nuclear
concentration was somewhat diminished (Supplementary
Figure S6B). Consistent with our model, the increase in
the cytoplasmic HuR levels in the NIH 3T3-SV3neo cells
was accompanied by an increase in the overall HuR
protein expression (Supplementary Figure S6C).
To test if the slightly reduced nuclear HuR protein con-
centration in the NIH 3T3-SV3neo had any effect on the
total HuR mRNA expression and the relative abundance
of the alternatively polyadenylated mRNA species, we
carried out RT–qPCR using primers speciﬁc to either all
mRNA forms (F1/R1, see diagram in Figure 2A) or just
the long species terminated at the PAS4 sites (F4/R4).
This analysis showed that the expression of the SV3neo
cassette indeed correlated with a 1.6-fold increase in the
total HuR mRNA levels (P=4.3 10
 4) and a 2-fold
decrease in the ratio between the PAS4-terminated and
the total mRNA levels (Supplementary Figure S6D
and E). These data suggest that the overall increase in
the HuR protein levels in SV40 LTA-transformed NIH
3T3 cells might be due to both its accumulation in the
cytoplasm where it fails to contribute to the negative
feedback regulation and a decrease in its nuclear
presence leading to an elevated production of the
PAS2-terminated mRNA species.
DISCUSSION
Here we show that mammalian HuR protein auto-
regulates its expression through a negative feedback
loop, whereby it binds to its own pre-mRNA and increases
the expression of long mRNA species containing a
destabilizing ARE sequence (Figure 7). This mechanism
may ensure HuR homeostasis when the nucleocytoplasmic
distribution of this protein remains relatively constant
or undergoes programmed reversible ﬂuctuations as
it happens during the cell cycle (16,27). On the other
hand, our model may provide at least a partial explan-
ation to the earlier reports that the increase in the
total HuR expression levels in cancer cells is often
accompanied by sequestration of a large fraction of
HuR in the cytoplasm (49,51–63). Indeed, since only the
nuclear HuR is expected to contribute to the negative
feedback auto-regulation, a sustained HuR accumulation
in the cytoplasm would result in the overall increase in
the intracellular HuR protein levels (Supplementary
Figure S6).
The newly identiﬁed homeostatic mechanism shares
common features with the auto-regulatory loop described
for the Drosophila ELAV protein (41,68). In both cases,
Hu/ELAV proteins interact with 30 segments of their cor-
responding pre-mRNAs. However, an important distinc-
tion between the two systems is that the ELAV protein
functions by changing the pattern of alternative splicing,
which leads to the appearance of a non-functional ELAV
mRNA (41). On the other hand, HuR stimulates the ex-
pression of unstable alternatively polyadenylated HuR
mRNAs.
Mammalian HuR and its nervous system-speciﬁc
paralogs have previously been shown to regulate
cleavage and polyadenylation of CT/CGRP and an
SV40 virus pre-mRNA by interacting with U-rich se-
quences adjacent to the PAS hexanucleotides (37).
Similar to our results, HuR reduces CstF-64 binding to
these pre-mRNAs. Interestingly, the Drosophila ELAV
protein also represses the 30-end pre-mRNA processing
of some pre-mRNA species but the CstF-64 binding is
not affected in this case (39) Thus, despite the apparent
functional similarity between ELAV and the Hu proteins,
distinct molecular mechanisms may underlie the ELAV/
Hu regulation in different metazoan organisms.
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by interacting with the adjacent GRE (Supplementary
Figure S1B). Since the GRE contains multiple copies
of the optimal HuR binding motifs (7), we predict
that binding of several HuR protein molecules upstream
and/or downstream of the PAS2 may be required to
interfere with the recruitment of CstF-64 and potentially
other pre-mRNA cleavage/polyadenylation factors. Since
HuR protein is capable of dimerization through the
RRM3 domain (69,77), it is conceivable that its interaction
with the GRE sequence occurs in a cooperative manner.
This would ensure that the PAS2 is promptly inactivated
when the nuclear HuR concentration exceeds a threshold
level. Further studies will address this possibility.
Notably, the HuR mRNA species terminated at the
PAS2 contain the 50-terminal half of the GRE sequence,
which may theoretically interact with the HuR protein
on its own. Wang and colleagues (46) have shown that
HuR indeed binds the 30-terminal segment of the
PAS2-terminated HuR mRNA, although the exact
location of the binding site(s) has not been determined.
The authors propose that this interaction may be
required for the export of HuR mRNA, which reduces
the HuR expression in senescent cells as a result of
nuclear retention of the HuR protein–mRNA complex
(46). Thus, the PAS2-adjacent GU-rich sequences may
potentially play opposite roles in senescent and
proliferating cells being a part of a positive feedback in
the former and a negative feedback in the latter.
Khabar and colleagues (48) have previously
demonstrated that the ARE sequence from the human
HuR destabilizes a reporter mRNA in a TTP-dependent
manner and that overexpressed HuR protein rescues the
mRNA stability. Consistent with this data, we ﬁnd that
mouse HuR also stimulates the expression of reporters
constructs containing a short fragment of the mouse
HuR 30-UTR that spans the ARE sequence. However,
mouse HuR failed to signiﬁcantly stimulate the expression
of a reporter construct containing the ARE within the
full-length HuR 30-UTR context. It is possible that
the HuR protection of the ARE sequence is hindered in
the full-length 30-UTR by the RNA secondary structure or
unknown trans-factors. Interestingly, human HuR has
been shown to bind its mRNA at a site located down-
stream of the PAS2 but distinct from the ARE (10).
Although the biological signiﬁcance of this interaction
has not been studied, it is possible that the mouse coun-
terpart(s) of this sequence modulate the HuR ARE-
protective effect.
RBPs play an essential part in the posttranscriptional
control of gene expression, which requires precise regula-
tion of their cellular levels (1–4). A growing body of work
suggest that this goal is often achieved through a variety
of auto-regulatory homeostatic mechanisms where RBP
proteins interact with their own (pre-) mRNAs in a
manner that triggers a reduced mRNAs stability or/and
translational efﬁciency. (2,78–80). It appears that HuR, a
master regulator of the mRNA metabolism in
proliferating mammalian cells, provides a compelling
example of this regulatory trend.
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